Akari Therapeutics
AKTX | NASDAQ
$8.10
-$0.15 (-1.82%)
Nov 2, 2026, 10:33 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -32.82M | -29.9M | -19.15M | -15.73M | -12.27M | -17.93M | -19.79M | -20.16M | -20.13M | -16.58M | -10.01M | -5.87M | -3M | -4.68M | -10.86M | -16.65M | -18.1M | -16.76M | -17.42M | -18.46M | -16.09M | -19.19M |
Depreciation & Amortization | n/a | n/a | n/a | 1K | 1K | 1K | 14K | 14K | 15K | 16K | 4K | 4.03K | 4.05K | 3.99K | 4K | 3.98K | 3.99K | 4.1K | 4.13K | 4.12K | 4.07K | 6.06K |
Stock-Based Compensation | 2.21M | 2.21M | 2.92M | 2.99M | 3.24M | 2.52M | 1.8M | 848.45K | 905.45K | 1.18M | 1.15M | 846K | 541.26K | 388.11K | 221.95K | 298.99K | 369.35K | 328.59K | 314.65K | 318.19K | 328.68K | 309.91K |
Other Working Capital | -953.23K | -7.23K | -275.83K | 1.12M | 3.04M | 3.46M | 4.49M | 3.14M | 1.84M | 1.46M | -698K | -891K | -934.8K | -3.52M | -2.85M | -1.95M | -2.13M | 298.12K | -1.74M | 16.37K | -224.46K | 990.66K |
Other Non-Cash Items | 22.15M | 18.76M | 7.05M | 3.09M | -3.03M | 1.29M | 936.99K | 1.32M | 1.58M | -1.68M | -6.88M | -6.11M | -6.19M | -5.64M | -141.51K | -91.27K | -88.62K | -105.34K | 242.5K | 43.61K | -1.24M | 1.25M |
Deferred Income Tax | -1.95M | -1.95M | -1.09M | -1.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -330.23K | -7.23K | -275.83K | 1.12M | 3.04M | 3.46M | 4.49M | 3.14M | 1.84M | 1.46M | -698K | -891K | -934.8K | -3.52M | -2.85M | -2.2M | -2.37M | 56.82K | -1.98M | 16.37K | -224.46K | 990.66K |
Operating Cash Flow | -10.74M | -10.89M | -10.55M | -9.63M | -9.02M | -10.66M | -12.55M | -14.84M | -15.8M | -15.6M | -16.43M | -12.02M | -9.58M | -13.46M | -13.63M | -18.63M | -20.19M | -16.48M | -18.85M | -18.08M | -17.22M | -16.63M |
Capital Expenditures | -3.68 | -3.68 | -3.68 | -3.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | 382K | 382K | 382K | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -15K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -15K | n/a | n/a | 382K | 382K | 382K | 382K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt Repayment | 1.45M | 1.44M | 1.06M | 206.47K | -2.04M | -1.15M | -855K | 118K | 454K | -215K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -1K | -1K | -1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -1.56K | -728.56K | 361.35K | 360.35K | 388K | 1.12M | 28K | 32K | 7K | 8K | 5K | 2K | 7.46K | 6.46K | 6.46K | 6.46K | n/a | n/a | n/a | n/a | n/a | 27.5K |
Financial Cash Flow | 15.72M | 11.07M | 13.15M | 9.54M | 7.23M | 11.61M | 10.99M | 12.35M | 12.79M | 5.32M | 7.02M | 3.5M | 3.51M | 3.22M | 12.37M | 13.49M | 24.67M | 26.66M | 14.29M | 19.17M | 7.99M | 15.2M |
Net Cash Flow | 4.98M | 186K | 2.6M | 298K | -1.41M | 1.33M | -1.19M | -2.49M | -3M | -10.27M | -9.41M | -8.52M | 2.07M | -2.1M | 6.92M | 2.9M | 4.36M | 10.05M | -4.69M | 1.07M | -8.95M | -1.15M |
Free Cash Flow | -10.74M | -10.88M | -10.55M | -9.63M | -9.02M | -10.66M | -12.55M | -14.84M | -15.8M | -15.6M | -16.43M | -12.02M | -9.58M | -13.46M | -13.63M | -18.63M | -20.19M | -16.48M | -18.85M | -18.08M | -17.22M | -16.63M |
Adj. Free Cash Flow | -12.94M | -13.1M | -13.47M | -12.62M | -12.26M | -13.18M | -14.35M | -15.69M | -16.7M | -16.78M | -17.58M | -12.87M | -10.12M | -13.85M | -13.85M | -18.93M | -20.56M | -16.81M | -19.16M | -18.39M | -17.55M | -16.94M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | -3.68 | -3.68 | -3.68 | -3.68 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Owner Earnings | -10.74M | -10.88M | -10.55M | -9.63M | -9.02M | -10.66M | -12.55M | -14.84M | -15.8M | -15.6M | -16.43M | -12.02M | -9.58M | -13.46M | -13.63M | -18.63M | -20.19M | -16.48M | -18.85M | -18.08M | -17.22M | -16.63M |
Add to Watchlist
Select watchlists to add or remove AKTX